IL1B and neoplasm: The abundance of IL1β along with the high myeloid influencing cytokine/chemokine milieu of PDAC portal blood could synergistically support CTC survival, both by acting directly on CTC and through influencing myeloid cell differentiation to M-FB which simultaneously support CTC cluster formation and block activation of anti-tumor immune responsive T cells (Fig 9A).